{"DataElement":{"publicId":"2685798","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria 046 Type","preferredDefinition":"the type of element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"AMC_PT_E_CTEC_046_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2518234","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"AMC_PT_EXCLU_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2518228","version":"1","preferredName":"AIDS Malignancy Consortium Patient","preferredDefinition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.:A person who requires medical care.","longName":"C19707:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS Malignancy Consortium","conceptCode":"C19707","definition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08C6-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518232","version":"1","preferredName":"Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"Exclusion; the act of restricting entrance or barring from participation.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25370:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1844-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1855-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2685799","version":"1","preferredName":"046 Exclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of clinical trial eligibility exclusion criteria for an AIDS Malignancy Consortium 046 protocol.","longName":"046_EXCL_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Is the participant pregnant or breast-feeding","valueDescription":"Is the participant pregnant or breast-feeding","ValueMeaning":{"publicId":"2685804","version":"1","preferredName":"Is the participant pregnant or breast-feeding","longName":"2685804","preferredDefinition":"Is the participant pregnant or breast-feeding","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BBFFB61-42BA-0993-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BC163B6-8205-20A6-E044-0003BA3F9857","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"ONEDATA","dateModified":"2007-10-05","deletedIndicator":"No"},{"value":"Does the participant have concurrent neoplasia requiring cytotoxic therapy","valueDescription":"Does the participant have concurrent neoplasia requiring cytotoxic therapy","ValueMeaning":{"publicId":"2685803","version":"1","preferredName":"Does the participant have concurrent neoplasia requiring cytotoxic therapy","longName":"2685803","preferredDefinition":"Does the participant have concurrent neoplasia requiring cytotoxic therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BC12A4D-92A8-0925-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BC163B6-8217-20A6-E044-0003BA3F9857","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"ONEDATA","dateModified":"2007-10-05","deletedIndicator":"No"},{"value":"Is the participant receiving corticosteroid treatment, other than replacement doses","valueDescription":"Is the participant receiving corticosteroid treatment, other than replacement doses","ValueMeaning":{"publicId":"2685802","version":"1","preferredName":"Is the participant receiving corticosteroid treatment, other than replacement doses","longName":"2685802","preferredDefinition":"Is the participant receiving corticosteroid treatment, other than replacement doses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BC13F5F-0A3D-09BA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BC163B6-8229-20A6-E044-0003BA3F9857","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"ONEDATA","dateModified":"2007-10-05","deletedIndicator":"No"},{"value":"Does the participant have untreated invasive cancer of the lower genital tract","valueDescription":"Does the participant have untreated invasive cancer of the lower genital tract","ValueMeaning":{"publicId":"2685801","version":"1","preferredName":"Does the participant have untreated invasive cancer of the lower genital tract","longName":"2685801","preferredDefinition":"Does the participant have untreated invasive cancer of the lower genital tract","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BC15EED-0937-0939-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BC163B6-823B-20A6-E044-0003BA3F9857","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"ONEDATA","dateModified":"2007-10-05","deletedIndicator":"No"},{"value":"Does the participant have acute, active opportunistic infection (other than oral thrush, yeast vaginitis, or genital herpes) within the last 14 days","valueDescription":"Does the participant have acute, active opportunistic infection (other than oral thrush, yeast vaginitis, or genital herpes) within the last 14 days","ValueMeaning":{"publicId":"2685809","version":"1","preferredName":"Does the participant have acute, active opportunistic infection (other than oral thrush, yeast vaginitis, or genital herpes) within the last 14 days","longName":"2685809","preferredDefinition":"Does the participant have acute, active opportunistic infection (other than oral thrush, yeast vaginitis, or genital herpes) within the last 14 days","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BC166F6-398B-09C0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BC15DC6-97DB-0991-E044-0003BA3F9857","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"ONEDATA","dateModified":"2007-10-05","deletedIndicator":"No"},{"value":"Is the participant receiving acute treatment for an infection (other than oral thrush, yeast vaginitis or genital herpes) or other serious medical illness within 14 days of study entry","valueDescription":"Is the participant receiving acute treatment for an infection (other than oral thrush, yeast vaginitis or genital herpes) or other serious medical illness within 14 days of study entry","ValueMeaning":{"publicId":"2685808","version":"1","preferredName":"Is the participant receiving acute treatment for an infection (other than oral thrush, yeast vaginitis or genital herpes) or other serious medical illness within 14 days of study entry","longName":"2685808","preferredDefinition":"Is the participant receiving acute treatment for an infection (other than oral thrush, yeast vaginitis or genital herpes) or other serious medical illness within 14 days of study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BC165BC-CBA1-21BF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BC15DC6-97ED-0991-E044-0003BA3F9857","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"ONEDATA","dateModified":"2007-10-05","deletedIndicator":"No"},{"value":"Has the subject received topical treatment for perianal dysplasia within 4 weeks of study entry","valueDescription":"Has the subject received topical treatment for perianal dysplasia within 4 weeks of study entry","ValueMeaning":{"publicId":"2990032","version":"1","preferredName":"Has the subject received topical treatment for perianal dysplasia within 4 weeks of study entry","longName":"2990032","preferredDefinition":"Has the subject received topical treatment for perianal dysplasia within 4 weeks of study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D9A2CC4-FA76-5256-E040-BB89AD435F53","latestVersionIndicator":"Yes","beginDate":"2010-01-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-01-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7D9A2CC4-FA8F-5256-E040-BB89AD435F53","beginDate":"2010-01-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-01-20","modifiedBy":"ONEDATA","dateModified":"2010-01-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BC12B58-2346-0937-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Exclusion Criteria","type":"Preferred Question Text","description":"Exclusion Criteria","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BC124CE-CA41-0A01-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}